Ajmera Herbals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 20-12-2024
- Paid Up Capital ₹ 3.00 M
as on 20-12-2024
- Company Age 24 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 M
as on 20-12-2024
- Satisfied Charges ₹ 9.00 M
as on 20-12-2024
- Revenue -6.20%
(FY 2020)
- Profit -93.29%
(FY 2020)
- Ebitda -7.14%
(FY 2020)
- Net Worth 17.01%
(FY 2020)
- Total Assets -7.34%
(FY 2020)
About Ajmera Herbals
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹5.00 M. The company has closed loans amounting to ₹9.00 M, as per Ministry of Corporate Affairs (MCA) records.
Rohan Ajmera, Gaurav Ajmera, and Rajesh Ajmera serve as directors at the Company.
- CIN/LLPIN
U00241MP2000PLC014338
- Company No.
014338
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
01 Aug 2000
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ajmera Herbals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurav Ajmera  | Director | 18-Dec-2000 | Current |
| Rohan Ajmera | Director | 27-Apr-2009 | Current |
| Rajesh Ajmera | Director | 18-Dec-2000 | Current |
Financial Performance of Ajmera Herbals.
Ajmera Herbals Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 6.2% decrease. The company also saw a substantial fall in profitability, with a 93.29% decrease in profit. The company's net worth Soared by an impressive increase of 17.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ajmera Herbals?
In 2020, Ajmera Herbals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ajmera Healthcare Private LimitedActive 16 years 5 monthsRohan Ajmera, Gaurav Ajmera and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 12 May 2017 | ₹5.00 M | Open |
Central Bank Of India Creation Date: 05 Oct 2012 | ₹9.00 M | Satisfied |
How Many Employees Work at Ajmera Herbals?
Unlock and access historical data on people associated with Ajmera Herbals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ajmera Herbals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ajmera Herbals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
